Poster De Conférence Année : 2024

Re-exploring the salicylanilide scaffold for the inhibition of mycolic acid synthesis in Mycobacterium tuberculosis

Résumé

Tuberculosis (TB) remains a global health crisis, further exacerbated by the slow pace of progress in developing new treatment options, and the emergence of extreme and total drug resistance to existing drugs. Infection cases keep increasing yearly, with a global number of 7.5 million of people diagnosed in 2022. As for other bacterial bugs, the most pressing challenge lies in the urgent need of finding new active compounds, acting through novel modes of action to tackle resistances. A unique feature of Mycobacterium tuberculosis (Mtb), the causative agent of TB, is its complex and lipid-rich cell envelope. Therefore, targeting the biosynthesis pathway of cell envelope mycolic acids is a historical strategy against Mycobacterium tuberculosis, yet the enzyme FadD32 is still an underexplored although highly relevant (and druggable) target. We have previously developed a miniaturized automatized enzymatic assay, which allowed the high-throughput screening of a drug repurposing library containing 1280 approved human or veterinary drugs (Prestwick Chemical Library). We obtained 36 hits that we further validated for their phenotypic activity on M. tuberculosis (MIC 0.08 – 10 µM). This led to identification of one promising pharmacophore, presenting a salicylanilide scaffold that we are now studying further by synthesizing and evaluating derivatives. Exploring SARs, we develop a hit to a lead medicinal chemistry project, searching for a novel anti-tubercular candidate targeting FadD32. The preliminary results of this approach will be presented.

Domaines

Chimie
Fichier principal
Vignette du fichier
20241209_Poster_AMR_FadD32_V3.pdf (1.05 Mo) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04883625 , version 1 (13-01-2025)

Identifiants

  • HAL Id : hal-04883625 , version 1

Citer

Gwenaëlle Jézéquel, Said Aït Taleb, Chérine Mehalla, Nguyen-Hung Le, Messie Muipata-Muabilua, et al.. Re-exploring the salicylanilide scaffold for the inhibition of mycolic acid synthesis in Mycobacterium tuberculosis. Tackling antibacterial and antifungal resistant infections from disease to innovative therapies, Dec 2024, Paris, France. ⟨hal-04883625⟩
0 Consultations
0 Téléchargements

Partager

More